Clinical trial
Metabolomic Study of Patients With Cardiomyopathy in China
NCT03061994 is registered in ClinicalTrials.gov with Beijing Institute of Heart, Lung and Blood Vessel Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolomic Study of Patients With Cardiomyopathy in China
- Lead sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2016
- Completion date
- October 31, 2020
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmogenic right ventricular cardiomyopathy, dilated cardiomyopathy, hypertrophic cardiomyopathy, left ventricular non-compaction, restrictive cardiomyopathy